Correlation Between Cue Biopharma and Star Equity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Star Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Star Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Star Equity Holdings, you can compare the effects of market volatilities on Cue Biopharma and Star Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Star Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Star Equity.

Diversification Opportunities for Cue Biopharma and Star Equity

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cue and Star is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Star Equity Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Star Equity Holdings and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Star Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Star Equity Holdings has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Star Equity go up and down completely randomly.

Pair Corralation between Cue Biopharma and Star Equity

Considering the 90-day investment horizon Cue Biopharma is expected to generate 4.33 times more return on investment than Star Equity. However, Cue Biopharma is 4.33 times more volatile than Star Equity Holdings. It trades about 0.13 of its potential returns per unit of risk. Star Equity Holdings is currently generating about -0.29 per unit of risk. If you would invest  82.00  in Cue Biopharma on September 3, 2024 and sell it today you would earn a total of  40.00  from holding Cue Biopharma or generate 48.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Cue Biopharma  vs.  Star Equity Holdings

 Performance 
       Timeline  
Cue Biopharma 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cue Biopharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Cue Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
Star Equity Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Star Equity Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Cue Biopharma and Star Equity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cue Biopharma and Star Equity

The main advantage of trading using opposite Cue Biopharma and Star Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Star Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Star Equity will offset losses from the drop in Star Equity's long position.
The idea behind Cue Biopharma and Star Equity Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges